News | July 23, 2014

Young Women With Heart Attacks Continue to Fare Worse Than Men

heart attacks, women's health

While awareness campaigns may be getting women to go to the hospital more quickly during a heart-attack, a new look at hospital data shows women have longer hospital stays and are more likely than men to die in the hospital after a heart attack. In the study published online in the Journal of the American College of Cardiology, researchers from Yale School of Medicine analyzed 230,684 hospitalizations for heart attack in patients age 30 to 54 from a total of 1.1 million hospitalizations reported in a national database from 2001 to 2010. The study found that heart attack hospitalization rates for patients under age 55 have not declined as quickly as they have for Medicare-age patients, which have seen a 20 percent drop. 
 
“This trend suggests we need to raise awareness of the importance of controlling cardiovascular risk factors like diabetes, high blood pressure and smoking in younger patients,” said lead author Aakriti Gupta, M.D.
 
All patient groups in the study saw increases in coexisting medical conditions including high blood pressure and diabetes. Men were more likely to have high cholesterol while women, especially black women, were more likely to also have hypertension, diabetes and heart failure. The authors concluded that younger women may benefit from more aggressive control of modifiable cardiovascular risk factors, including early identification and treatment of high blood pressure, high cholesterol, obesity, smoking and diabetes.
 
“Younger women are a vulnerable yet understudied group with worse cardiac risk profiles and worse outcomes after a heart attack as compared with younger men,” Gupta said. 
 
For more information: www.cardiosource.org/acc

Related Content

News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
Subscribe Now